Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Corporate Insolvency
Insolvency Risks
Tax Compliance Violations
Asset Seizure
Workforce Reductions
Ethics Violations Allegations
Financial Reporting Irregularities
Insider Trading Violations
Explosion and Gas Leak Incidents
Fire Incident Impact
Logistics & Transportation Disruptions
Illicit Financial Practices
Offshore Tax Practices
Legal Scandals
Labor Exploitation
Government Corruption
Product Quality Compliance
Safety Compliance Violations
Product Recall
Regulatory and Legal Emergencies
Corporate Fraud
Corporate Financial Crises
Fraud Investigations
Child Labor Violations
Financial Crime Investigations
Financial Statement Revisions
Debt Strategy and Obligations
Activist Short Selling
Investor Sentiment Trends
War
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2023-06-12 (bnnbloomberg.ca)
Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis AG agreed to buy the drug developer in a deal for up to $3.5 billion.
Read more